Exam 3 Flashcards

1
Q

What are the two Calcineurin Inhibitors?

A

Cyclosporine A

Tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the antimetabolites?

A
  • Mycophenolate Mofetil
  • Mycophenolate Sodium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mTor?

A

Sirolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What makes cyclosporine a good canditate for drug monitoring?

What is its most common and serious SE?

A
  • It is large and poorly soluble so that gives it a poor bioavailability
  • Nephrotoxicity is the side effect and one of the reasons for TDM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is cyclosporines Black Box?

A

Monitoring needs to be done

to avoid toxicity due to high concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What kinetics does cyclosporine follow?

A

Linear, dose-proportionate PK within the therapeutic range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CsA PK Factors that affect it

What enhances absorption?

Bioavailability is reduced in what?

F increases with inhibition of?

A
  • Food effect, high calorie meals increase absorption
  • F is reduced in reduced bile production (liver transplant)
  • F is increased with inhibition of p-gp and gut CYP3A4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CsA PK Factors that affect it

Clearance?

A
  • Increased in children
  • Reduced in pts with hepatic dysfunction (including immediately after liver transplant)
  • Increased with induction of CYP3A4
  • Reduced with inhibition of CYP3A4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the primary measurement of exposure for Tacrolimus?

A

Trough levels good correlation with AUC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Time Since Transplant is a factor that alters target levels of exposure and how does this work?

A
  • As time increases risk of rejection decreases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Age can affect target levels of exposure what is the difference in child vs adults?

A
  • Children overall have a lower risk of rejection but each follow a similar trend
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The organ being transplanted can affect target levels of exposure how?

A
  • Liver vs Kidney
  • Liver shows a lower risk of rejection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pts can be on other therapies while how does induction affect target levels of exposure?

A
  • Pts that are not on induction therapy typically need a higher target level of exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where you are taking your samples in the body can affect target levels of exposure what is the difference between Blood and Plasma levels?

A
  • Drugs like CsO, Tacrolimus, Sirolimus are highly bound to Erythrocytes which are found in whole blood so your concentration levels if taken from blood will be much higher than if taken from just plasma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CsA What is the best measurement for target levels of exposure?

A
  • 2 hour post dose peak levels (levels taken within 10 minutes either way will give you a 10% variability in target levels and pose the risk of posible overdose for the pt)
  • Trough is taken sometimes but is more variable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What levels are measured in Tacrolimus and Sirolimus?

A
  • Trough levels and have the same variability parameters as CsA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the wild tpe fully function CYP2D6?

18
Q

How many whites have deficient CYP2D6?

A

5-10% of caucasians

19
Q

What consitutes a PM for CYP2D6 or others?

A

They must have two “inactive” forms of the alleles

20
Q

What percentage of the Asain population are PMs?

A
  • 1% but overall CYP2D6 functionality as a whole is lower than whites
21
Q

What is the effect of a poor metabolizer?

A

PMs are at increased risk for concentration dependent SEs when given normal dosing but increased effect can occur (tramadol, codiene)

22
Q

What are the alleles that are non functional for CYP2D6?

23
Q

What are the wild types or green allel>

24
Q

Characteristics of UMs

CYP2D6

A
  • Will have much higher clearance of drug therefore need higher doses
  • But on the other end danger of overdose with other drugs (codiene)
25
What percentage of white and asain population are poor metabolizers of CYP2C19?
* 2-5% whites * 20-25% Asians
26
WHat allele has increased activity in CYP2C19?
\*17 this is different compare to 2D6 because \*17 is a partially active allele.
27
WHat drugs have actiivty terminated by CYP2C19?
PPIs S-Citalopram Diazepam
28
What medication is activated by 2C19?
Clopidogrel
29
What are the inactive allelels for CYP2C19?
2, 3
30
What is the wild type allele for CYP2C19?
1
31
CYP2C19 \*17 allele is highest in what population? Lowest in?
Highest in whites and ethiopiansn Lowest In asians
32
What things make up the most influence on Warfarin?
VKORC1 and CYP2C9
33
What statins are in the lactone form?
Compactin, Simvastatin, Lovastatin
34
What is the OATP mutant assoicated with increased myopathy? What is the result in the body?
* OATP1B1\*5 * SLCO1B1\*5 * Result is decrease uptake of statin into the liver and an increase in blood resulting in increased blood concentrations of statins increasing Myopathy
35
What effect does OATP1B1 \*5 have on a lactone form of a statin?
Nothing lactone forms are absorbed via passive diffusion The acidic forms of statin increase concentrations in the blood
36
What is the reference for OATP1B1 and what is the carrier?
TT CC
37
For a TC or CC what therapy do you use?
Lower the dose or switch to statin thats a lactone
38
What 3 statins are subject to a more dramatic decrease in dose if someone is a carrier of? Which medication requires no increase?
* Simvastatin (80-20) * Pitavastatin (4-1) * Atorvastatin (80-20) * IF they are a carrier of OATP1B1\*5 CT or CC * Fluvastatin no change
39
Where is MDR1 found in the body ?
B/w hepatocyte and bile hepatocyte to bile and brain remove drug molecule from the brain to the blood
40
What UGTP1A1 mutations reduce enzymatic activity? When do they occur most?
\*28 and \*6 White-28 Asian 6
41
Irinotecan
Duarrhea and mylosuppression
42
WHat mutation of UGT1A1 is a significant predictor of toxicity of Irinotecan?
\*28 decreases Cl increasing AUC